The pharmacogenetics of lithium response depends upon clinical co-morbidity.
about
Polymorphisms in melatonin synthesis pathways: possible influences on depressionMolecular actions and clinical pharmacogenetics of lithium therapyThe role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.Towards the clinical implementation of pharmacogenetics in bipolar disorder.Response to lithium in bipolar disorder: clinical and genetic findings.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association studyThe interaction of BDNF and NTRK2 gene increases the susceptibility of paranoid schizophreniaThe promise and reality of pharmacogenetics in psychiatryIncreased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.Predictors of lithium response in bipolar disorder.Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorderPharmacogenetic considerations in the treatment of psychiatric disorders.Pharmacogenomics of bipolar disorder.Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms.Childhood trauma and treatment outcome in bipolar disorder.Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.History repeats itself: the family medication history and pharmacogenomics.Lithium and Circadian Rhythms
P2860
Q24288941-06A8AA25-AEBC-462E-8865-41E53FB64AF6Q28307770-596C3441-B353-47D1-8E0E-F5A55DA484D8Q30576881-6E73BF3D-70AE-4C5E-9E28-A5285CCF7C7CQ33688133-E4D502A1-BDD5-4C60-A73A-672910B56120Q33777973-1824D494-0D8F-4190-892E-08247D1A04FFQ34146222-05567A7D-F26F-4105-A0B3-CFF4723183FDQ34229583-B76F3949-D63B-41EB-9318-F07361E715C8Q34999082-0E91DBFC-706A-41EB-A0C4-340B777AFDB9Q35226451-8727D9D4-1B10-416A-88C6-428C4BFF773EQ36251776-ECD4B3F4-0F92-4470-8B58-E27B239F9376Q36443736-8F061F60-4B4E-4D0B-9A8E-89E538180483Q36699480-96093B17-6E33-4490-B229-410CE9EDAD2EQ36856165-92836BED-C951-4A78-951C-99D2EDEF4AEBQ37681573-74CA5E9F-0097-4E0C-9B9E-5035AB6CBC27Q38097534-991A8BD2-A2D9-4494-9E0E-0D3164C3FC79Q39502405-95789676-34EF-4EC6-B560-74F6D456C0D3Q47875065-8E7D9848-F204-4568-892C-19583405EA50Q48068187-626569DD-5F8F-4787-B6DC-6C4EAA1D5BE6Q48406708-7296FBD7-CD79-4E82-8459-61FE98428349Q50856364-6C1AA1DA-4872-4F8F-8BC2-75B260A41538Q57831326-B8873DFB-0555-49C2-B056-8C252F34BBBC
P2860
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@en
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@nl
type
label
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@en
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@nl
prefLabel
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@en
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@nl
P2093
P2860
P356
P1476
The pharmacogenetics of lithium response depends upon clinical co-morbidity.
@en
P2093
Chris Herold
Cornelius Diamond
John R Kelsoe
Rebecca McKinney
Tatyana Shehktman
Thomas B Barrett
Troy Bremer
P2860
P2888
P304
P356
10.1007/BF03256238
P577
2007-01-01T00:00:00Z
P6179
1031419422